Loading...
Thrombolytic therapy for pulmonary embolism
BACKGROUND: Thrombolytic therapy is usually reserved for people with clinically serious or massive pulmonary embolism (PE). Evidence suggests that thrombolytic agents may dissolve blood clots more rapidly than heparin and may reduce the death rate associated with PE. However, there are still concern...
Na minha lista:
| Udgivet i: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley & Sons, Ltd
2021
|
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8092433/ https://ncbi.nlm.nih.gov/pubmed/33857326 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD004437.pub6 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|